12/11/2026
📣 Reminder: our next SMAcademy webinar is coming up soon!
“Tracing patient experiences with SMA medicines, access, and treatment journeys in Europe: Open discussion on SMA Europe’s Pan-European Patient-Experience Survey”
🗓️ 17 November 2026
⏰ 14:00–15:30 CET
The SMA medicine and treatment landscape is changing rapidly. But how are people living with SMA navigating this increasingly complex environment?
To better understand these experiences, SMA Europe conducted the European Patient Experience Survey (EUPESMA), exploring access to SMA medicines and individual treatment journeys across Europe. The findings reveal that treatment journeys are not always straightforward. They can involve disruptions, delays and changes in direction, highlighting the importance of understanding individual experiences to improve care, support and advocacy.
💬 Join us for an interactive discussion!
We will share key findings from 826 people living with SMA and caregivers across more than 40 countries, while inviting patient advocates to reflect on the results and explore how we can turn these insights into meaningful action.
📌 Please note that the Q&A session will be open to patient advocates only.
🔗 There is still time to register here: https://bit.ly/481o6D1
Together, 🌍
[Description of slides. Slide one: Blue slide reminding readers about the upcoming SMAcademy webinar, “Tracing patient experiences with SMA medicines, access, and treatment journeys in Europe: Open discussion on SMA Europe’s Pan-European Patient-Experience Survey,” taking place on 17 November 2026 from 14:30 to 16:00 CET. It notes that the SMAcademy Webinar Series is designed for patient advocates and that the Q&A session will be open to patient advocates only. Slide two: Blue closing slide with the SMA Europe logo, , and www.sma-europe.eu.]